Cargando…
Late and booster anti‐SARS‐CoV‐2 humoral responses in nonresponder vaccinated patients with rheumatic diseases receiving mycophenolate or rituximab: comment on the article by XXX et al
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wiley Periodicals, Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347727/ https://www.ncbi.nlm.nih.gov/pubmed/35588445 http://dx.doi.org/10.1002/acr2.11446 |
| _version_ | 1784761875889651712 |
|---|---|
| author | Bakasis, Athanasios‐Dimitrios Goules, Andreas V. Vlachoyiannopoulos, Panayiotis G. Bitzogli, Kleopatra Tzioufas, Athanasios G. |
| author_facet | Bakasis, Athanasios‐Dimitrios Goules, Andreas V. Vlachoyiannopoulos, Panayiotis G. Bitzogli, Kleopatra Tzioufas, Athanasios G. |
| author_sort | Bakasis, Athanasios‐Dimitrios |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9347727 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Wiley Periodicals, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93477272022-08-03 Late and booster anti‐SARS‐CoV‐2 humoral responses in nonresponder vaccinated patients with rheumatic diseases receiving mycophenolate or rituximab: comment on the article by XXX et al Bakasis, Athanasios‐Dimitrios Goules, Andreas V. Vlachoyiannopoulos, Panayiotis G. Bitzogli, Kleopatra Tzioufas, Athanasios G. ACR Open Rheumatol Letters to the Editor Wiley Periodicals, Inc. 2022-05-19 /pmc/articles/PMC9347727/ /pubmed/35588445 http://dx.doi.org/10.1002/acr2.11446 Text en © 2022 The Authors. ACR Open Rheumatology published by Wiley Periodicals LLC on behalf of American College of Rheumatology. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Letters to the Editor Bakasis, Athanasios‐Dimitrios Goules, Andreas V. Vlachoyiannopoulos, Panayiotis G. Bitzogli, Kleopatra Tzioufas, Athanasios G. Late and booster anti‐SARS‐CoV‐2 humoral responses in nonresponder vaccinated patients with rheumatic diseases receiving mycophenolate or rituximab: comment on the article by XXX et al |
| title | Late and booster anti‐SARS‐CoV‐2 humoral responses in nonresponder vaccinated patients with rheumatic diseases receiving mycophenolate or rituximab: comment on the article by XXX et al |
| title_full | Late and booster anti‐SARS‐CoV‐2 humoral responses in nonresponder vaccinated patients with rheumatic diseases receiving mycophenolate or rituximab: comment on the article by XXX et al |
| title_fullStr | Late and booster anti‐SARS‐CoV‐2 humoral responses in nonresponder vaccinated patients with rheumatic diseases receiving mycophenolate or rituximab: comment on the article by XXX et al |
| title_full_unstemmed | Late and booster anti‐SARS‐CoV‐2 humoral responses in nonresponder vaccinated patients with rheumatic diseases receiving mycophenolate or rituximab: comment on the article by XXX et al |
| title_short | Late and booster anti‐SARS‐CoV‐2 humoral responses in nonresponder vaccinated patients with rheumatic diseases receiving mycophenolate or rituximab: comment on the article by XXX et al |
| title_sort | late and booster anti‐sars‐cov‐2 humoral responses in nonresponder vaccinated patients with rheumatic diseases receiving mycophenolate or rituximab: comment on the article by xxx et al |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347727/ https://www.ncbi.nlm.nih.gov/pubmed/35588445 http://dx.doi.org/10.1002/acr2.11446 |
| work_keys_str_mv | AT bakasisathanasiosdimitrios lateandboosterantisarscov2humoralresponsesinnonrespondervaccinatedpatientswithrheumaticdiseasesreceivingmycophenolateorrituximabcommentonthearticlebyxxxetal AT goulesandreasv lateandboosterantisarscov2humoralresponsesinnonrespondervaccinatedpatientswithrheumaticdiseasesreceivingmycophenolateorrituximabcommentonthearticlebyxxxetal AT vlachoyiannopoulospanayiotisg lateandboosterantisarscov2humoralresponsesinnonrespondervaccinatedpatientswithrheumaticdiseasesreceivingmycophenolateorrituximabcommentonthearticlebyxxxetal AT bitzoglikleopatra lateandboosterantisarscov2humoralresponsesinnonrespondervaccinatedpatientswithrheumaticdiseasesreceivingmycophenolateorrituximabcommentonthearticlebyxxxetal AT tzioufasathanasiosg lateandboosterantisarscov2humoralresponsesinnonrespondervaccinatedpatientswithrheumaticdiseasesreceivingmycophenolateorrituximabcommentonthearticlebyxxxetal |